The clearance of Redemplo for a rare genetic disorder marks Arrowhead’s transition, after two decades, into a ...
The Dako Omnis test identifies mismatch repair deficiencies in colorectal cancer, aiding in treatment decisions and potentially improving patient outcomes. Hernexeos, a kinase inhibitor, offers a new ...
Genmab ( ($GMAB) ) just unveiled an update. On November 18, 2025, Genmab A/S announced that the U.S. FDA approved EPKINLY® (epcoritamab-bysp) in ...
As Roche works to switch certain patients with breast cancer over to a fixed-dose combination of two medicines, its ...
Lynozyfic received accelerated approval for relapsed multiple myeloma, showing a 70% response rate but with notable side effects, including cytokine release syndrome and neurologic toxicity. Zegfrovy ...
Amazon S3 on MSN
FDA Approved Drugs That Eventually Got Banned
FDAApprovedToBanned #pharmaceutical #didyouknow #medicine #facts #list25 Uncover the shocking truth behind 25 FDA-approved ...
On Monday, July 14, the FDA announced that it has approved the use of the natural color additive gardenia (genipin) blue for dying a variety of foods and drinks. This is the fourth natural color that ...
GSK plc GSK announced that the FDA has approved its blockbuster respiratory drug, Nucala (mepolizumab), for a fifth indication. The drug is now cleared to treat certain patients with chronic ...
Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars annually. If someone you know has Alzheimer’s, you’ve likely experienced ...
FRIDAY, Sept. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback